Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 2NIH 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Dermatologic 3134Thoracic 566Genitourinary 484Gastrointestinal 457Breast 366Head & Neck 339Gynecologic 289Sarcoma 224CNS 206Lymphoid 115Other hematologic neoplasm 67Other solid neoplasm 65Endocrine 47Plasma cell 36Myeloid 29NET 13Classical hematology 6Other neoplasm 3Other 1

Conditions

Precancerous Conditions 213Lymphoma 47Leukemia 46Multiple Myeloma 44Leukemia, Lymphocytic, Chronic, B-Cell 42Neoplasms, Plasma Cell 40Precursor Cell Lymphoblastic Leukemia-Lymphoma 39Monoclonal Gammopathy of Undetermined Significance 39Lymphoma, Non-Hodgkin 38Lymphoma, Mantle-Cell 37Lymphoma, Large-Cell, Immunoblastic 37Lymphoma, Large B-Cell, Diffuse 37Lymphoma, Follicular 37Myelodysplastic Syndromes 36Burkitt Lymphoma 36Lymphoma, B-Cell, Marginal Zone 35Leukemia, Myeloid, Acute 35Hodgkin Disease 35Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 34Myeloproliferative Disorders 34Immunoglobulin Light-chain Amyloidosis 33Waldenstrom Macroglobulinemia 32Immunoblastic Lymphadenopathy 32Uterine Cervical Neoplasms 31Lymphoma, Large-Cell, Anaplastic 31Primary Myelofibrosis 30Thrombocythemia, Essential 29Leukemia, Hairy Cell 29Leukemia, Biphenotypic, Acute 29Uterine Cervical Dysplasia 28

Interventions

tremelimumab 1Watchful Waiting 1Ribavirin 1Lovastatin 1Infliximab 1Chromatography, High Pressure Liquid 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Melanoma × Other neoplasm × Clear all
NCT04625491 2021-02-10

Location of Lower Limb Cutaneous Melanomas as a Prognostic Factor.

Hospital Universitario Virgen de la Arrixaca

Unknown
300 enrolled
DermatologicOther neoplasm

Melanoma, Pathological Conditions, Anatomical

NCT00897312 2016-04-25

Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease

Vanderbilt-Ingram Cancer Center

Terminated
7 enrolled
DermatologicOther neoplasm

Hepatitis C, Melanoma, Precancerous Conditions

NCT00462280 2014-10-31

Lovastatin in Treating Patients At High Risk of Melanoma

National Cancer Institute (NCI)

Phase 2 Completed
80 enrolled 35 charts
DermatologicOther neoplasm

Melanoma, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡